Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells

Anticancer effect of altersolanol A, a metabolite produced by the endophytic fungus Stemphylium globuliferum, mediated by its pro-apoptotic and anti-invasive potential via the inhibition of NF-κB activity

(2013) Marie-Hélène Teiten et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer

(2013) Dong Hoon Suh et al.   CLINICAL AND EXPERIMENTAL MEDICINE

New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential

(2013) S. Banerjee et al.   CLINICAL CANCER RESEARCH

Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake

(2013) William A Flavahan et al.   NATURE NEUROSCIENCE

Targeting cellular metabolism to improve cancer therapeutics

(2013) Y Zhao et al.   Cell Death & Disease

Inhibition of Development of Abdominal Aortic Aneurysm by Glycolysis Restriction

(2012) Toshihiro Tsuruda et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

(2012) Patrick S. Ward et al.   CANCER CELL

Preoperative [18F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer

(2012) Hyun Hoon Chung et al.   Journal of Gynecologic Oncology

The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer

(2012) C. P. Carden et al.   MOLECULAR CANCER THERAPEUTICS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer

(2011) Jae Hong No et al.   GYNECOLOGIC ONCOLOGY

Targeting cancer metabolism: a therapeutic window opens

(2011) Matthew G. Vander Heiden   NATURE REVIEWS DRUG DISCOVERY

Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines

(2010) Stacy R. Millon et al.   BREAST CANCER RESEARCH AND TREATMENT

Expression of GLUT-1 in epithelial ovarian carcinoma: Correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction

(2010) Assaad Semaan et al.   GYNECOLOGIC ONCOLOGY

The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer

(2010) L. D. Kellenberger et al.   Journal of Oncology

Genistein Inhibits Cell Growth by Modulating Various Mitogen-Activated Protein Kinases and AKT in Cervical Cancer Cells

(2009) Su-Hyeon Kim et al.   Annals of the New York Academy of Sciences

Clinical Significance of FDG Single-Photon Emission Computed Tomography: Computed Tomography in the Diagnosis of Head and Neck Cancers and Study of Its Mechanism

(2009) Ling-Fa Li et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression

(2008) Carolyn L. Buller et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis

(2008) A. Montel-Hagen et al.   BLOOD

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

(2008) Joydeb Kumar Kundu et al.   CANCER LETTERS

Effect of Akt overexpression on programmed cell death in antibody-producing Chinese hamster ovary cells

(2008) Sun Ok Hwang et al.   JOURNAL OF BIOTECHNOLOGY

A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death

(2008) T. E. Wood et al.   MOLECULAR CANCER THERAPEUTICS